US-EU trade deal wards off further escalation but will raise costs for companies, consumers

The recently announced US-EU trade deal imposes a 15% tariff on most European goods entering the U.S., including cars, chips, and pharmaceuticals, thereby averting President Trump's previously threatened 30% rate. While preventing a broader escalation, this tariff, significantly higher than historical averages, is projected to increase costs for U.S. consumers and reduce profits for European exporters, with the EU having already lowered its growth forecast from 1.3% to 0.9%. The agreement also features zero tariffs on strategic goods, plus EU commitments for $750 billion in U.S. energy purchases and $600 billion in U.S. investments, though specifics on steel tariffs and pharmaceuticals remain unresolved, indicating persistent economic challenges for European industries despite mitigating the worst-case trade scenario.

Analysis

The new US-EU trade agreement establishes a 15% tariff on most European goods, a development that averts a threatened 30% rate but solidifies a trade environment of significantly higher costs compared to the historical average of approximately 1%. While the deal mitigates the risk of a more severe transatlantic trade war, it is poised to compress margins for European exporters and raise prices for US consumers. The European Union's executive commission had already revised its annual growth forecast downward from 1.3% to 0.9% in anticipation of a 10% tariff, indicating the new 15% rate will institutionalize this economic drag. The automotive sector, though seeing its tariff rate fall from a recent 27.5%, still faces a substantial headwind; Volkswagen's reported €1.3 billion profit impact from prior tariffs illustrates the financial stakes, and Mercedes-Benz anticipates significant price increases despite its partial US production buffer. The agreement's impact is made more complex by its unresolved components, including the persistence of a 50% US steel tariff and ambiguity surrounding pharmaceutical tariffs. Offsetting these negatives are the EU's commitments to purchase $750 billion in US energy and invest an additional $600 billion in the US, alongside zero tariffs on a select list of strategic goods, though as noted by ING's analyst, the deal's lack of a finalized text introduces an element of caution.

Key Decisions for Investors

• Investors should re-evaluate margin forecasts for European exporters, particularly in the automotive, chip, and pharmaceutical sectors, as the 15% tariff will likely pressure profitability despite providing relief from a worse-case scenario.
• Consider increasing exposure to the US energy sector, as the EU's explicit $750 billion purchase commitment for oil, gas, and nuclear fuel provides a significant and durable demand tailwind.
• Monitor US consumer-facing stocks for signs of demand elasticity and inflationary pressure, as higher import costs on European goods will either be passed on to consumers or absorbed by retailers, impacting sales and margins.
• Maintain a cautious stance on sectors with unresolved trade terms, such as steel and potentially pharmaceuticals, as the lack of finality in the agreement represents continued policy risk.